Pregnant women with hyperglycaemia are at increased risk of birth complications, malformations and adverse intrauterine programming.1,2 Moderate intensity exercise improves maternal glycaemic control and reduces weight-gain.3,4 Lifestyle education improves fetal outcomes for women with gestational diabetes.5 ACSM and ACOG guidelines recommend 30 minutes moderate-intensity daily activity after the first trimester.6,7 There is little evidence to guide exercise intervention for pregnant women with type 2 diabetes or early hyperglycaemia.
Twenty-four women with type 2 diabetes or early (<20 weeks gestation) hyperglycaemia (ADIPS) were given lifestyle education and randomised to either incremental individualised physical activity targets from baseline (13-19 weeks) to 34 weeks gestation (n=10, intervention) or standard care (n=14, control). The intervention group wore a pedometer daily, were encouraged to identify an exercise partner8 and activity targets were increased by +10% (maximum target 10,000 steps/day) at each routine clinic visit. The control group did not receive targets, but wore a pedometer for one week at baseline, 26 and 34 weeks gestation. The activity levels of the fifteen women who completed the study increased from baseline to 26 weeks (4806±426 vs. 5775±669 steps/day), and declined to 34 weeks (4612±388 steps/day). The intervention group demonstrated an attenuated reduction in activity at 34 weeks (n=7, 5203±561 steps/day) compared to control (n=8, 4095±497 steps/day; Figure). Mean fasting glucose levels at 28 weeks were significantly reduced from baseline in the intervention group (-0.4±0.1mmol/l vs. -0.1±0.0mmol/l; Figure).
A pedometer-based intervention was mostly effective at improving activity levels in pregnancy. There was a low completion rate suggesting the intervention may not be sustainable. This cohort of women had lower activity levels than those of obese pregnant women published in the literature.9,10 Larger studies should investigate the acceptability and feasibility of exercise interventions and their impact on both maternal and fetal outcomes in this higher-risk group.